vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and PACS Group, Inc. (PACS). Click either name above to swap in a different company.

PACS Group, Inc. is the larger business by last-quarter revenue ($1.4B vs $1.0B, roughly 1.3× Alignment Healthcare, Inc.). PACS Group, Inc. runs the higher net margin — 4.4% vs -1.1%, a 5.5% gap on every dollar of revenue. On growth, Alignment Healthcare, Inc. posted the faster year-over-year revenue change (44.4% vs 18.4%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (26.9% CAGR vs 20.5%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

ALHC vs PACS — Head-to-Head

Bigger by revenue
PACS
PACS
1.3× larger
PACS
$1.4B
$1.0B
ALHC
Growing faster (revenue YoY)
ALHC
ALHC
+26.0% gap
ALHC
44.4%
18.4%
PACS
Higher net margin
PACS
PACS
5.5% more per $
PACS
4.4%
-1.1%
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
26.9%
20.5%
PACS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALHC
ALHC
PACS
PACS
Revenue
$1.0B
$1.4B
Net Profit
$-11.0M
$59.7M
Gross Margin
Operating Margin
-1.0%
7.0%
Net Margin
-1.1%
4.4%
Revenue YoY
44.4%
18.4%
Net Profit YoY
64.6%
3022.5%
EPS (diluted)
$-0.04
$0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
PACS
PACS
Q4 25
$1.0B
$1.4B
Q3 25
$993.7M
$1.3B
Q2 25
$1.0B
$1.3B
Q1 25
$926.9M
$1.3B
Q4 24
$701.2M
$1.1B
Q3 24
$692.4M
$1.0B
Q2 24
$681.3M
$981.4M
Q1 24
$628.6M
$934.3M
Net Profit
ALHC
ALHC
PACS
PACS
Q4 25
$-11.0M
$59.7M
Q3 25
$3.7M
$52.4M
Q2 25
$15.7M
$51.0M
Q1 25
$-9.1M
$28.5M
Q4 24
$-31.1M
$1.9M
Q3 24
$-26.4M
$15.6M
Q2 24
$-24.0M
$-10.9M
Q1 24
$-46.5M
$49.1M
Gross Margin
ALHC
ALHC
PACS
PACS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
17.1%
Q2 24
22.3%
Q1 24
21.2%
Operating Margin
ALHC
ALHC
PACS
PACS
Q4 25
-1.0%
7.0%
Q3 25
0.8%
6.4%
Q2 25
2.2%
6.2%
Q1 25
-0.6%
3.8%
Q4 24
-3.2%
1.7%
Q3 24
-2.8%
2.2%
Q2 24
-2.7%
0.1%
Q1 24
-6.5%
8.6%
Net Margin
ALHC
ALHC
PACS
PACS
Q4 25
-1.1%
4.4%
Q3 25
0.4%
3.9%
Q2 25
1.5%
3.9%
Q1 25
-1.0%
2.2%
Q4 24
-4.4%
0.2%
Q3 24
-3.8%
1.5%
Q2 24
-3.5%
-1.1%
Q1 24
-7.4%
5.3%
EPS (diluted)
ALHC
ALHC
PACS
PACS
Q4 25
$-0.04
$0.42
Q3 25
$0.02
$0.32
Q2 25
$0.07
$0.31
Q1 25
$-0.05
$0.17
Q4 24
$-0.15
$-0.03
Q3 24
$-0.14
$0.10
Q2 24
$-0.13
$-0.07
Q1 24
$-0.25
$0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
PACS
PACS
Cash + ST InvestmentsLiquidity on hand
$604.2M
$197.0M
Total DebtLower is stronger
$323.2M
$353.2M
Stockholders' EquityBook value
$179.3M
$946.8M
Total Assets
$1.1B
$5.6B
Debt / EquityLower = less leverage
1.80×
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
PACS
PACS
Q4 25
$604.2M
$197.0M
Q3 25
$644.1M
$355.7M
Q2 25
$503.8M
$294.2M
Q1 25
$479.5M
$287.5M
Q4 24
$470.6M
$157.7M
Q3 24
$381.0M
$49.5M
Q2 24
$363.7M
$73.4M
Q1 24
$301.7M
$81.2M
Total Debt
ALHC
ALHC
PACS
PACS
Q4 25
$323.2M
$353.2M
Q3 25
$322.7M
Q2 25
$322.3M
Q1 25
$321.9M
Q4 24
$321.4M
$411.9M
Q3 24
$212.0M
Q2 24
$211.7M
Q1 24
$162.0M
Stockholders' Equity
ALHC
ALHC
PACS
PACS
Q4 25
$179.3M
$946.8M
Q3 25
$161.9M
$871.3M
Q2 25
$141.0M
$806.8M
Q1 25
$108.1M
$750.2M
Q4 24
$99.9M
$709.6M
Q3 24
$114.5M
$660.0M
Q2 24
$123.7M
$572.1M
Q1 24
$130.9M
$128.0M
Total Assets
ALHC
ALHC
PACS
PACS
Q4 25
$1.1B
$5.6B
Q3 25
$1.1B
$5.6B
Q2 25
$1.0B
$5.5B
Q1 25
$895.6M
$5.5B
Q4 24
$782.1M
$5.2B
Q3 24
$692.3M
$4.5B
Q2 24
$716.3M
$3.9B
Q1 24
$633.2M
$3.9B
Debt / Equity
ALHC
ALHC
PACS
PACS
Q4 25
1.80×
0.37×
Q3 25
1.99×
Q2 25
2.29×
Q1 25
2.98×
Q4 24
3.22×
0.58×
Q3 24
1.85×
Q2 24
1.71×
Q1 24
1.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
PACS
PACS
Operating Cash FlowLast quarter
$-50.4M
$-3.4M
Free Cash FlowOCF − Capex
$-55.4M
FCF MarginFCF / Revenue
-5.5%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
-0.06×
TTM Free Cash FlowTrailing 4 quarters
$113.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
PACS
PACS
Q4 25
$-50.4M
$-3.4M
Q3 25
$144.6M
$204.8M
Q2 25
$29.1M
$52.6M
Q1 25
$16.6M
$150.2M
Q4 24
$-8.7M
$64.6M
Q3 24
$26.2M
$209.2M
Q2 24
$23.5M
$34.8M
Q1 24
$-6.2M
$58.8M
Free Cash Flow
ALHC
ALHC
PACS
PACS
Q4 25
$-55.4M
Q3 25
$139.1M
Q2 25
$21.1M
Q1 25
$8.4M
Q4 24
$-18.0M
Q3 24
$16.9M
Q2 24
$11.8M
Q1 24
$-17.4M
FCF Margin
ALHC
ALHC
PACS
PACS
Q4 25
-5.5%
Q3 25
14.0%
Q2 25
2.1%
Q1 25
0.9%
Q4 24
-2.6%
Q3 24
2.4%
Q2 24
1.7%
Q1 24
-2.8%
Capex Intensity
ALHC
ALHC
PACS
PACS
Q4 25
0.5%
Q3 25
0.6%
Q2 25
0.8%
Q1 25
0.9%
Q4 24
1.3%
Q3 24
1.3%
Q2 24
1.7%
Q1 24
1.8%
Cash Conversion
ALHC
ALHC
PACS
PACS
Q4 25
-0.06×
Q3 25
38.77×
3.91×
Q2 25
1.86×
1.03×
Q1 25
5.28×
Q4 24
33.78×
Q3 24
13.39×
Q2 24
Q1 24
1.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons